JJP-1008 | m-entrepreneurship.com

Product Name :
JJP-1008

Search keywords :
HVEM

drugId :
null

Target Vo:
Tumor necrosis factor receptor superfamily member 14

Target Vo Short Name :
TNFRSF14

Moa_Name:
Tumor necrosis factor receptor superfamily member 14 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Jjp Biologics Sp. z o.o.

Active Company_Name :
Jjp Biologics Sp. z o.o.

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
COX2 Antibody
Cytochrome P450 17A1 Antibody
Synaptophysin Antibody (YA043): Synaptophysin Antibody (YA043) is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Synaptophysin. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts